scholarly journals Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?

2012 ◽  
Vol 132 (2) ◽  
pp. 417-426 ◽  
Author(s):  
Britton Trabert ◽  
Nicolas Wentzensen ◽  
Hannah P. Yang ◽  
Mark E. Sherman ◽  
Albert R. Hollenbeck ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Menopausal Hormone Therapy ◽  
Endometrial Cancer Risk ◽  
Estrogen Plus Progestin

Discussion: ‘Long-term postmenopausal hormone therapy and endometrial cancer risk’ by Doherty et al

2007 ◽  
Vol 197 (2) ◽  
pp. e1-e5 ◽  
Author(s):  
Randall R. Odem ◽  
Michelle H. Moniz ◽  
Jenifer E. Allsworth ◽  
Christy R. Bleckman ◽  
Valerie A. Omicioli ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Postmenopausal Hormone Therapy ◽  
Endometrial Cancer Risk ◽  
Postmenopausal Hormone

scholarly journals Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH–AARP Diet and Health Study Cohort

2012 ◽  
Vol 23 (3) ◽  
pp. 487-496 ◽  
Author(s):  
Louise A. Brinton ◽  
Lauren Schwartz ◽  
Margaret R. Spitz ◽  
Yikyung Park ◽  
Albert R. Hollenbeck ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Lung Cancer Risk ◽  
Menopausal Hormone Therapy ◽  
Health Study ◽  
Study Cohort ◽  
Unopposed Estrogen ◽  
Estrogen Plus Progestin

Long-term postmenopausal hormone therapy and endometrial cancer risk: a study by Doherty et al

2007 ◽  
Vol 197 (2) ◽  
pp. 213-214 ◽  
Author(s):  
Randall R. Odem ◽  
Michelle H. Moniz ◽  
Jenifer E. Allsworth ◽  
Christy R. Bleckman ◽  
Valerie A. Omicioli ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Postmenopausal Hormone Therapy ◽  
Endometrial Cancer Risk ◽  
Postmenopausal Hormone

MENOPAUSAL HORMONOTHERAPY IN ONCOGYNECOLOGIC PATIENTS

2017 ◽  
Vol 63 (6) ◽  
pp. 843-854
Author(s):  
Olga Novikova ◽  
Yelena Ulrikh ◽  
V. Nosov ◽  
A. Charkhifalakyan
Keyword(s):  
Quality Of Life ◽  
Cervical Cancer ◽  
Endometrial Cancer ◽  
Hormone Replacement Therapy ◽  
Hormone Therapy ◽  
Replacement Therapy ◽  
Hormone Replacement ◽  
Menopausal Hormone Therapy ◽  
Oncological Safety

There is presented the review of domestic and foreign references on the conserved oncological safety of the use of menopausal hormone therapy after treatment for endometrial cancer, cervical cancer, borderline and malignant ovarian tumors, various variants of sarcomas of the uterus, vulva and vaginal cancer. To the opinion of the authors the refusal to prescribe menopausal hormone therapy to patients with oncogynecologic diseases in the anamnesis is usually not justified, the category of patients, to whom hormone replacement therapy is contraindicated, is well described and mentioned in the text. In other cases sex hormones can be used to treat menopausal symptoms and improve the quality of life of patients.

Endometrial cancer risk after fertility treatment: a population-based cohort study

2021 ◽  
Author(s):  
Sonia Guleria ◽  
Allan Jensen ◽  
Vanna Albieri ◽  
Bugge Nøhr ◽  
Kirsten Frederiksen ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cohort Study ◽  
Cancer Risk ◽  
Population Based ◽  
Fertility Treatment ◽  
Endometrial Cancer Risk
Sign in / Sign up

Export Citation Format

Share Document